“…Recent preclinical studies have reported that secretomes from MSC have the potential for treating some intractable diseases as acute myocardial infarction [16], fulminant hepatic failure [43], renal failure [44], [45], ischemic stroke [46], experimental autoimmune encephalomyelitis [47] and hypoxic brain injury [48] and for the repair of soft tissues [49]. Also, has been reported that MSC-CM has a very high potential for bone regeneration, mediated by the cooperative effects of cytokines such as IGF-1, TGF-ß1 [50], [51], VEGF, angiogenin [50], HGF (Hepatocyte growth factor) [51], BMP-1 [52], IL-6, IL-3, MCP-1 (Monocyte Chemoattractant Protein-1) and MCP-3 (Monocyte Chemoattractant Protein-3) [41]. These cytokines regulate several events of osteogenesis, angiogenesis, cell migration, proliferation, and osteoblast differentiation [50].…”